Sector: Chemicals

Latest content

CAFC decision highlights continued danger of inequitable conduct rulings

The Federal Circuit’s judgment in a recent pharma patent case is a stark reminder that IP professionals must remain vigilant

16 September 2021

With little overseas patent footprint, a Chinese battery champion faces its first litigation

A Zhuhai company that has grown to be the world’s second largest supplier of laptop and tablet batteries faces new US patent claims as it prepares to go public

10 September 2021

Bolsonaro vetoes Brazil’s first-of-a-kind compulsory tech transfer law

The president’s rejection of forced know-how licensing will now be reviewed by the country’s Congress, but a new patent suspension regime is set to come into force

03 September 2021

As solar patent war rolls on, Chinese panel leader says it has seen off biggest threats

JinKo Solar explains how a Sino-Korean patent battle has played out so far, revealing big differences in US and German results

27 August 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other legal practice areas - becomes a Law Business Research company

25 August 2021

Legal challenges to the PTAB’s NHK-Fintiv discretionary denial regime mount

Life sciences companies are among those leading the way in going to court to get the current rules struck down

20 August 2021

Brazil on the cusp of passing landmark compulsory technology transfer law

Life sciences innovators may be compelled to hand over trade secrets, data and biological materials under legislation that now only requires President Bolsonaro’s signature to become law

19 August 2021

A defensive strategy for China can help multinationals avoid bad faith patent litigation

Companies can take steps to reduce the chance that they’re targeted with a low-quality patent

19 August 2021

New study shows surge in data-driven and computer-assisted healthcare patents

Boom in digital healthcare and bioinformatics IP requires strategic adjustments in both the life sciences and high-tech arenas

17 August 2021

$235 million CAFC decision creates confusion around skinny-label generics, says dissenting judge

The Federal Circuit hands down its second ruling in the carvedilol dispute between Teva and GSK, following widespread concern over its first

13 August 2021

Unlock unlimited access to all IAM content